The SPIN Thoracic Navigation System is a stereotactic accessory for Computed Tomography (CT) and endosopic bronchoscope systems. The SPiN Thoracic Navigation System is indicated for displaying:

· An interventional instrument such as a biopsy needle, an aspiration needle on a computer monitor that also displays a CT-based model of the target organ(s).

· Images of the tracheobronchial tree to aid a physician in guiding endoscopic tools, catheters or guidewires in the pulmonary tract.

The SPiN Thoracic Navigation System compensates for the patient's respiratory phases.

The SPIN Thoracic Navigation System is in clinical interventions and for anatomical structures where computed tomography and/or endoscopic bronchoscopy are currently used for visualizing such procedures.

The SPiN Thoracic Navigation System enables marker placement in soft lung tissue.

Device Description

The SPiN Thoracic Navigation System is an accessory for a CT system that utilizes electromagnetic tracking technology to locate and navigate endoscopic tools, catheters and guidewires relative to a CT-based model of the tracheobronchial tree. Due to system use to locate structures in soft tissue. the system incorporates a method of gating the location information on soft tissue to the patient's respiration. The SPiN Thoracic Navigation System consists of an EM tracking accessory, a patient referencing system, an EM field generator and tracking system, software, a computer system, and a pulmonary pathway reconstruction and planning workstation. The EM tracking accessories that can be used with the SPiN Thoracic Navigation System include Veran's Always-On Tip Tracked™ Guidewire, Sheath, Aspiration Needle, Brush, Forceps or View Peripheral Catheter. The SPiN Thoracic Navigation System also enables the placement of markers in soft tissue to guide radiosurgery and thoracic surgery. The SPiN View console/View Optical Probe is provided as an additional accessory for video visualization and is a complement to the EM tracking of the View Peripheral Catheter, enhancing the navigation of the device through the vocal chords and tracheobronchial tree.

AI/ML Overview

Here's a summary of the acceptance criteria and the study information for the SPiN Thoracic Navigation System, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criterion	Reported Device Performance
Software Verification & Validation	The SPiN Drive and SPiN Planning software applications successfully fulfilled the requirements defined in the Software Requirement Specifications and Software Design Specifications.
Navigational Accuracy (Static Phantom)	Testing results met the predetermined acceptance criteria established in test protocols. (Specific accuracy metrics are not provided in this document).
Electrical Safety (System)	Met all requirements of AAMI/ANSI/IEC 60601-1.
Electromagnetic Compatibility (System)	Met all requirements of IEC 60601-1-2.
Electrical Safety (Endoscopic Equipment)	The SPiN View console met all requirements of IEC 60601-2-18.
Laser Classification (SPiN View System)	Classified as a Class 3R laser light source, which is "safe if handled correctly with restricted beam viewing" with a "low risk of injury" for exceeding the maximum permissible exposure (MPE). (Safety confirmed, not a specific performance metric but a classification result).
EO Sterilization Validation	All instrumentation can be appropriately sterilized to the currently validated ethylene oxide sterilization cycle.
Biocompatibility of EO Sterilized Instruments	No biocompatibility issues exist with the instrumentation.
Functional Testing of Instrumentation	Demonstrated the durability of the instrumentation.
Video Visualization Accessory V&V	The video visualization system met all established requirements.
View Optical Probe Accessory Functional Testing	All established requirements were met.

2. Sample Size Used for the Test Set and Data Provenance

The document does not explicitly state the sample size used for the test set in terms of human subjects or patient data. The performance evaluations described are primarily focused on system-level testing, phantom studies, and accessory validation.

Test Set (Phantom): Used a "static phantom" for navigational accuracy testing. The number of samples/runs on the phantom is not specified.
Data Provenance: The document does not provide information about the country of origin of data or if it was retrospective or prospective, as the testing described focuses on device performance rather than patient studies.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

The document does not mention the use of experts to establish ground truth for the test set in the context of clinical interpretation or diagnostic accuracy. The ground truth for the technical performance tests (e.g., electrical safety, EMC, sterilization, phantom accuracy) would be defined by engineering specifications and objective measurements against those specifications.

4. Adjudication Method (for the test set)

No adjudication method is described, as the testing outlined is technical verification and validation against objective criteria rather than subjective human interpretation.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No multi-reader multi-case (MRMC) comparative effectiveness study is mentioned in the provided text. The document focuses on the technical performance and safety of the device itself, rather than comparing human reader performance with and without AI assistance.

6. Standalone (Algorithm Only) Performance Study

The document describes "Software verification and validation testing" which evaluated the algorithms' performance in fulfilling requirements and demonstrating navigational accuracy on a static phantom. This constitutes a standalone performance evaluation of the algorithms and system components in a controlled environment.

7. Type of Ground Truth Used

The ground truth used for the described studies is primarily:

Engineering Specifications/Requirements: For software, electrical safety, EMC, and overall system functionality, the ground truth is defined by the established technical specifications and regulatory standards (e.g., IEC 60601 series).
Physical Measurements: For navigational accuracy, the ground truth would be precise physical measurements on the static phantom.
Laboratory Analysis: For sterilization and biocompatibility, the ground truth is determined by validated laboratory test methods and results (e.g., confirming sterility, assessing material compatibility).

8. Sample Size for the Training Set

The document does not provide information on the sample size for any training set for machine learning models. The device relies on electromagnetic tracking technology, not explicitly stated machine learning models that would require a "training set" in the conventional sense of AI development for image interpretation. The software development process mentioned involves "Software Requirement Specifications" and "Software Design Specifications," which guide traditional software engineering.

9. How Ground Truth for the Training Set Was Established

As no training set for machine learning is explicitly mentioned, the establishment of ground truth for a training set is not applicable to the information provided.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The symbol is composed of three intertwined figures, representing people. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the symbol.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

May 15, 2017

Veran Medical Technologies, Inc. % Mr. Scott Wrightstone Director of QA/RA 1908 Innerbelt Business Center Drive ST. LOUIS MO 63114

Re: K170023

Trade/Device Name: SPiN Thoracic Navigation System Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: JAK Dated: May 1, 2017 Received: May 3, 2017

Dear Mr. Wrightstone:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Michael D'Hara

For

Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

510(k) Number (if known) K170023

Device Name SPiN Thoracic Navigation System

Indications for Use (Describe)

The SPIN Thoracic Navigation System is a stereotactic accessory for Computed Tomography (CT) and endosopic bronchoscope systems. The SPiN Thoracic Navigation System is indicated for displaying:

· An interventional instrument such as a biopsy needle, an aspiration needle on a computer monitor that also displays a CT-based model of the target organ(s).

· Images of the tracheobronchial tree to aid a physician in guiding endoscopic tools, catheters or guidewires in the pulmonary tract.

The SPiN Thoracic Navigation System compensates for the patient's respiratory phases.

The SPiN Thoracic Navigation System enables marker placement in soft lung tissue.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (8/14)

Page 1 of 1

PSC Publishing Services (301) 443-6740 EF

{3}------------------------------------------------

510(k) Summary Veran Medical Technologies Traditional 510(k) SPiN Thoracic Navigation System

1. Submitter

510(k) Submitter:

Veran Medical Technologies, Inc. 1908 Innerbelt Business Center Drive St. Louis, MO 63114

Contact:

Scott Wrightstone Director of Quality Assurance & Regulatory Affairs Phone: 314-659-8500 Fax: 314-659-8560

Date Prepared:

December 9, 2016

2. Subject Device

Trade Name:	SPIN Thoracic Navigation System
Common Name:	CT stereotactic accessory, Bronchoscope
Classification Name:	Computed Tomography X-ray System, Bronchoscope AccessoryBronchoscope (Flexible or Rigid)21 CFR 892.1750
Classification Code:	JAK, LLZ
Manufacturer:	Veran Medical Technologies, Inc.

3. Predicate Devices

Primary Predicate
Trade Name:	SPiN Drive
Common Name:	CT stereotactic accessory
510(k):	K122106
Classification Name:	Computed Tomography X-ray System21 CFR 892.1750
Classification Code:	JAK
Manufacturer:	Veran Medical Technologies, Inc.
Secondary Predicate
Trade Name:	inReach System
Common Name:	Bronchoscope
510(k):	K081379
Classification Name:	Computed Tomography X-ray System
Product Code:	JAK
Manufacturer:	superDimension, LTD

{4}------------------------------------------------

4. Device Description

5. Indications for Use

The SPiN Thoracic Navigation System is a stereotactic accessory for Computed Tomography (CT) and endoscopic bronchoscope Systems. The SPiN Thoracic Navigation System is indicated for displaying:

. An interventional instrument such as a biopsy needle, an aspiration needle, or ablation needle on a computer monitor that also displays a CT-based model of the target organ(s).
. Images of the tracheobronchial tree to aid a physician in guiding endoscopic tools, catheters or guidewires in the pulmonary tract.

The SPiN Thoracic Navigation System compensates for a patient's respiratory phases.

The SPiN Thoracic Navigation System is intended for use in clinical interventions and for anatomical structures where computed tomography and/or endoscopic bronchoscopy are currently used for visualizing such procedures.

The SPiN Thoracic Navigation System enables marker placement within soft lung tissue.

6. Summarv of Characteristics to Predicate Device

The SPiN Thoracic Navigation System and the predicate devices have the same intended use, use CT data for creating reference images, have electromagnetic tracking functionality, use instrumentation with sensors for navigation, have similar positioning accuracy, use pulmonary pathway and reconstruction software for planning, reconstruct CT datasets for pathway reconstruction and complete pathway planning through point selection on a 3D model of the tracheobronchial tree for pathway creation. The SPiN Thoracic Navigation System and the SPiN Drive additionally both have an intended use for percutaneous (needle) navigation, autodetection of reference markers on the CT image and patient, complete a geometry check for tool verification and gate navigation to the effects of respiration. The differences between the SPiN Thoracic Navigation System and the predicate devices include:

. Clarification of the indications for use to include intended use of enabling marker placement within soft lung tissue.
. The update of the SPiN Drive software with a new look/user experience and the ability to run on a Linux computer.

{5}------------------------------------------------

The introduction of a new electrical cart.
o Addition of the SPiN Perc Biopsy Needle Guide Kit, a convenience kit for percutaneous navigation of instrumentation during a SPiN Perc procedure.
o Addition of the Always-On Tip Tracked 22ga ANSO SPiNFlex Needle and Extended Working Channel (EWC), ethylene oxide sterilized accessories (the EWC has no sensor and is a non-navigated accessory).
Revision of the Always-On Tip Tracked Steerable Catheter accessory from a reusable accessory to a single-use, ethylene oxide sterilized accessory, with a name of View Peripheral Catheter.
. Change in sterilization methods for the Always-On Tip Tracked Guidewire to ethylene oxide sterilization from gamma radiation.
. Changes in packaging labeling due to the implementation of UDI labeling.
Incorporation of an additional visualization accessory in the form of the SPIN View console/View Optical Probe.

Risk management, performance testing, and design verification and validation activities have demonstrated that the changes to the SPiN Thoracic Navigation System do not have an effect on the safety and effectiveness of the device as the subject device conforms to all requirements and specifications.

7. Performance Data

Performance data presented to establish substantial equivalence to the predicate devices includes:

. Software verification and validation testing was performed to ensure that the SPiN Drive and SPiN Planning software applications successfully fulfilled the requirements defined in the Software Requirement Specifications (User Requirements) and Software Design Specifications (System Specifications). The verification and validation protocols included detailed descriptions of dependencies, execution instructions, required input, expected output and pass/fail criteria. This testing included demonstrating navigational accuracy on a static phantom. The testing results met the predetermined acceptance criteria that were established in the test protocols. Based on the verification and validation testing, the SPiN Drive and SPiN Planning software applications perform as intended, and it was confirmed that no new questions of safety or effectiveness were identified during testing.
. Electrical safety testing in accordance with AAMI/ANSI/IEC 60601-1 demonstrated that the SPiN Thoracic Navigation System and SPiN View console met all requirements.
. Electromagnetic Compatibility testing in accordance with IEC 60601-1-2 demonstrated that the SPiN Thoracic Navigation System and SPiN View console met all requirements.
. Electrical safety testing for endoscopic equipment in accordance with IEC 60601-2-18 demonstrated that the SPiN View console met all requirements.
. Laser classification was completed for the SPiN View system and it was classified as a Class 3R laser light source. Class 3R lasers are safe if handled correctly with restricted beam viewing. With a class 3R laser, the maximum permissible exposure (MPE) can be exceeded, but with a low risk of injury. Laser classification and hazards analysis has identified appropriate warnings for inclusion in labeling.
. EO sterilization validation was completed for all instrumentation and showed that the instrumentation can be appropriately sterilized to the currently validated ethylene oxide sterilization cycle.
Biocompatibility testing of EO sterilized instrumentation was completed and demonstrated that no biocompatibility issues exist with the instrumentation.

{6}------------------------------------------------

. Navigational accuracy on a static phantom was completed to demonstrate navigational accuracy of all instrumentation. Functional testing of the instrumentation was completed and demonstrated the durability of the instrumentation.
Video visualization accessory verification and validation testing, including firmware . verification and validation was completed and demonstrated that the video visualization system met all established requirements.
. View Optical Probe accessory functional testing was completed and demonstrated that all established requirements were met.

8. Conclusion

The information presented in the 510(k) submission supports that the SPiN Thoracic Navigation System was shown to be substantially equivalent to the predicate devices in providing electromagnetic navigational bronchoscopy and placing fiducial markers in soft lung tissue. Differences between the SPiN Thoracic Navigation System and the predicate devices do not have an effect on the safety and effectiveness of the SPiN Thoracic Navigation System as demonstrated through the performance data.

Regulation Number and Section

§ 892.1750 Computed tomography x-ray system.

(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.